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ABSTRACT 
Objective: From a total of 107 grants, a subset evaluation of 58 grants awarded to and completed by pharmacy faculty by the 
Community Pharmacy Foundation (CPF) from 2002 through 2014 was conducted to: (a) evaluate the representativeness across 
principal investigator (PI) academic institutions, (b) compare the scope of CPF grants completed by academic PIs across time, and (c) 
compare the impact of CPF grants completed by academic PIs across time. Methods: Quantitative data for all 107 CPF grants awarded 
between 2002 and 2014 were obtained from the CPF website and CPF personnel. Qualitative ethnographic data was generated from 
principal investigator (PI) interviews by email communications. All 107 grants, including a subset of 58 grants awarded to pharmacy 
faculty, were analyzed and compared between ‘Initial Years’ (2002-2008) and ‘Recent Years’ (2009-2014) using descriptive statistics 
for quantitative data and an extraction of dominant themes from PI reflections for qualitative data. Results:  In the initial years (2002-
2008), 54% of grants awarded to pharmacy faculty were from public academic institutions. This proportion increased to 80% in recent 
years (2009-2014). In recent years, pharmacy faculty projects were increasingly focused on higher AHRQ Impact Categories, such as 
changing policies and programs, clinical care and practice patterns, and health outcomes (AHRQ Impact Levels  
2-4), rather than simply adding to the knowledge base (Impact Level 1). Academic investigators reported that funding positively 
influenced practice development (59%), promotion & advancement (59%), and expanded collaborations (38%). Diverse geographic 
representation of funding recipients was achieved. Conclusions: CPF funding has been invaluable for investigators seeking experience 
securing grant funding.  And the impact of CPF funding has transitioned from studies that add to the knowledge base only, toward 
studies that effect actual health outcomes or that profoundly change practice. 
 
Keywords: Program Evaluation; AHRQ Impact Factor; Investigator Influence; Community Pharmacy, Grants 
 
 
INTRODUCTION 
The Community Pharmacy Foundation (CPF) is a non-profit 
organization that awarded over $7,000,000 between 2002 and 
2014 spread towards 107 grants and special projects to advance 
community pharmacy practice and patient care.1   The CPF’s 
major goals are to support: 
 
1. The development, processing, and use of findings 
that affirm the value of community pharmacy 
practice in the health care delivery system. 
2. The measurement, publication, and dissemination of 
findings documenting the value of professional 
services delivered to patients by community 
pharmacists.  
3. Efforts that measure the impact of pharmacist 
interventions in achieving the targeted therapeutic 
goals set collaboratively by the patient, the 
pharmacist and the other members of the health care 
team. 
4. Efforts that evaluate patient-specific outcomes with 
regard to the quality of care delivered by community 
pharmacists. 
 
 
Corresponding author: Anthony W. Olson, PharmD 
Email: olso2001@umn.edu 
Phone: 952-215-1874; Fax: 612-625-9951 
Grants are reviewed on a rolling basis four to five times  
per year during the Community Pharmacy Foundation  
Board of Directors meetings.  The current composition of  
the CPF Board is publicly available on the CPF website 
(http://www.communitypharmacyfoundation.org/about/boar
d.asp).   
 
In order to assess the degree to which CPF grants fulfilled these 
goals and to inform the Foundation’s awarding of future 
funding, the CPF collaborated with three University of 
Minnesota researchers in June of 2014 to design an evaluation 
of strategic decisions, trends, and impact of CPF funding.  The 
evaluation described and compared the 107 grants completed 
in the Foundation’s ‘Initial Years’ (2002-2008) and ‘Recent 
Years’ (2009-2014) in terms of representativeness, scope, and 
impact. A copy of the project synopsis can be found at the CPF 
website (http://communitypharmacyfoundation.org/). 
 
Findings from this report generated additional research 
questions related to the representative distribution of grants 
awarded to academic principal investigators (PIs) by 
geographical location, ranking, and time.  Therefore, of the 
total 107 CPF grants awarded and completed at the time of this 
program evaluation analysis, the subset of 58 grants awarded 
and completed by pharmacy faculty at 36 different schools and 
colleges of pharmacy served as the census for this analysis. 
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Study Objectives 
The objectives of this study were to: 
 
A. Evaluate the representativeness of PIs’ academic 
institution for (1) Public or Private and (2) Geographic 
Location. 
B. Compare the scope of CPF grants funding PIs at academic 
institutions by ‘Initial Years’ (2002-2008) and ‘Recent 
Years’ (2009-2014) for (3) Funding Level, (4) Three Part 
Aim, and (5) CPF Coordinated Use of Medications.  
C.  Compare the impact of CPF grants funding PIs at 
academic institutions by ‘Initial Years’ (2002-2008) and 
‘Recent Years’ (2009-2014) for (6) AHRQ Impact Factor 
and (7) CPF Investigator Reflections.  
 
METHODS 
Quantitative and qualitative data were collected between    
June 2015 and August 2015 from the CPF website,                         
CPF staff, and CPF grant awardees.  One researcher (AO) 
extracted 58 grants completed by PIs receiving salary support 
from an academic institution from a total pool of                             
107 grants acquired from the CPF Grant List 
(www.communitypharmacyfoundation.org/grants/grants_list
.asp).  These grants were then sorted by the year they were 
completed into one of two groups, ‘Initial Years’ (i.e., 2002-
2008) or ‘Recent Years’ (i.e., 2009-2014).  These evaluation 
time periods were selected in collaboration with the CPF Board 
of Directors to represent a natural line of demarcation 
between equal time periods of CPF funding, and also more 
rigorous proposal evaluation criteria and monitoring 
procedures in the ‘Recent Years.’ 
 
Categorization of the 58 CPF grants by the Three-part Aim, 
Coordinated Use of Medications, and AHRQ Impact Factor was 
completed by two researchers (AO and JS) serving as judges 
trained on the rules and procedures for coding. Each judge 
independently scored 30 grants and exceeded a threshold 
level of 90% agreement in scores. One researcher (AO) then 
completed the remainder of the coding for this study. 
 
A. Representativeness of Academic Institutions 
During the collaborative development of this evaluation, the 
CPF Board of Directors expressed interest in a description of the 
distribution, or diversity, of CPF funding across the country and 
among academic institutions.  To determine the degree of 
academic representation of CPF funding, the 36 academic 
institutions affiliated with the 58 faculty grant awards were 
described according to university type (i.e., public or private) 
and geographic location [(i.e., the eight (American Association 
of Colleges of Pharmacy (AACP) and National Association of 
Boards of Pharmacy (NABP) districts)]. 
 
 
 
B. Comparison of Scope between ‘Initial Years’ and ‘Recent 
Years’  
Funding Level 
The number and dollar amount awarded (expressed as 
categorical funding levels) for the 58 CPF project grants were 
computed directly from the CPF data files provided by the CPF 
Grants Administrator.  “Number of funded projects” was 
computed for each year and also for “Initial Years” (2002-2008) 
and “Recent Years” (2009-2014).  “Dollar amount” was defined 
as: (1) less than or equal to $1,000, (2) $1,001 to $25,000, (3) 
$25,001 to $50,000, (4) $50,001 to $100,000, and (5) greater 
than $100,000.  “Award Recipient Types” were categorized as: 
(1) academic institution or (2) non-academic organization. 
   
Three-Part Aim 
The 58 academic institution CPF projects were analyzed for 
contributions to the national, “Three-Part Aim”2 using the 
following categorizations:  
 
• Improving care for individual patients.  Projects with 
corresponding objectives and results that further the 
understanding, implementation, or evaluation of 
methods for “improving the individual experience of 
care” for patients. 
• Improving population health. Projects with 
corresponding objectives and results that further the 
understanding, implementation, or evaluation of 
methods for “improving the health of populations”. 
• Controlling health care costs through quality 
improvement.   Projects with corresponding objectives 
and results that further the understanding, 
implementation, or evaluation of methods for 
“reducing the per capita costs of care for populations”.  
 
Coordinated Use of Medications 
The 58 CPF projects were analyzed for contributions made to 
the “Coordinated Use of Medications,” which is part of the 
CPF’s Strategic Interests Plan,3 categorized as: 
 
• Payment reform.  Projects with results that further the 
understanding, implementation, or evaluation of 
global or budgeted payment models that standardize 
and incentivize indicated, effective, and safe 
medication use, and that engage patients in shared 
decision-making as adherent patients to help meet 
quality health goal performance benchmarks. 
• Delivery reform.  Projects with corresponding results 
that further the understanding, implementation, or 
evaluation of new payment models with accreditation 
or other prerequisites, as well as competitive 
strategies for delivering medication-related care and 
services within such systems.  
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• Real-time data integration.  Projects with results that 
further the understanding, implementation, or 
evaluation of health information environments that 
make available standardized, comprehensive, and 
real-time data at the point of care on the patient’s 
medication history and adherence that is crucial to 
effective and efficient medication use. 
 
C. Comparison of Impact between ‘Initial Years’ and 
‘Recent Years’  
AHRQ Impact Factor Framework 
The 58 CPF projects were analyzed using the AHRQ Impact 
Factor framework, which is an assessment tool developed to 
link findings in outcomes research studies with impact on 
improving the health of patients and changing practice.  This 
Impact Framework was developed to help stakeholders 
understand the “outcomes of outcomes research.”  There are 
four AHRQ Impact Factor levels.4  
 
• Level 1: Studies that add to the knowledge base only 
and do not represent a direct change in policy or 
practice. 
• Level 2: Studies that may lead to a policy or program 
change as a direct result of the research. 
• Level 3: Studies that may cause a potential change in 
what clinicians or patients do, or result in a change in 
a care pattern. 
• Level 4: Studies that may change actual health 
outcomes (clinical, economic, quality of life, and/or 
patient satisfaction), or profoundly change practice.  
 
CPF Investigator Reflections 
The impact of CPF funding on the careers of investigators was 
assessed by adapting ethnographic observation methods,5 or 
self-ethnography, using a semi-structured query to guide 
responses and reflections from grantees.  A total of 114 
principal investigators and co-principal investigators served as 
the frame of reference for this study objective.  Electronic-mail 
addresses were supplied by the CPF Grants Administrator, 
generating 99 current and valid e-mail addresses and 15 
investigators for whom no updated contact information was 
available.  These 99 CPF grantees included 58 academic primary 
investigators receiving salary support from an academic 
institution and 41 investigators who were not receiving salary 
support from an academic institution.    
 
An Invitation Letter with the following query was transmitted 
to all 99 investigators with valid e-mail addresses; with 
instructions to reply directly back to the P.I. via e-mail: 
 How has funding from the Community Pharmacy 
Foundation helped you in your career progression? 
 
As you reflect on your response, please consider  
how CPF funding has helped you in terms of 
subsequent funding opportunities, new or expanded 
collaborations, promotion and advancement, practice 
development, and/or reimbursement reform.  And 
please also let us know if your CPF project was 
continued with new funding has been replicated by 
others, and if your work has been recognized with any 
awards.  
 
Grantees were contacted with an initial Invitation Letter and 
asked to respond in 3-4 weeks.  A second request was sent to 
those individuals who did not respond at 4 weeks, and at 6 
weeks, after receiving the initial Invitation Letter.  And finally, 
individuals who did not respond after two months were 
contacted by telephone by the Principal Investigator (BI) to 
explain reasons for conducting the analysis and to encourage 
participation.   
 
The same methodological categorization rules, procedures, and 
processes were followed as that for the AHRQ Impact Factor 
analysis.  Two independent judges exceeded the 90% level of 
agreement in their scoring of 20 investigator influence 
reflections, and one researcher (AO) completed the remainder 
of the coding for this project evaluation objective. 
 
Data Analysis 
The first six objectives (A1-C6 listed in Study Objectives of the 
Introduction section) were analyzed using descriptive statistics 
to summarize the data. Given the data constituted a complete 
census, rather than a sample, inferential statistics (e.g., chi-
square p-value) were not used for comparisons and analysis. 
The last objective (C7) utilized qualitative data from PI 
reflections, which were analyzed by using a descriptive and 
interpretive ethnographic method.5,6  A single investigator on 
the research team (BI) read through PI reflections multiple 
times to mine for dominant themes.  The resulting themes were 
then discussed with the other members of the research team 
(JS and AO) and confirmed. 
 
RESULTS 
General Summary 
The 58 grant projects that were awarded to and completed by 
academic PIs over CPF’s lifetime (from 2002-2014) were used in 
this analysis.  On average, 4 grant proposals were funded per 
year (range 1 to 9 per year).  An average of five projects were 
completed each year (range from 0 to 13 per year).  Figure 1 
presents the number of CPF projects awarded to, and 
completed by, academic faculty by year.  Additionally, Table 1 
presents the 58 CPF completed grants by: (1) Name of 
Institution, (2) Institution Type, (3) Number of CPF Grants 
Completed, (4) AACP/NABP District Number, and (5) Number of 
Investigator Impact Responses Received. 
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Figure 1: Number of CPF Projects Awarded to, and Completed by,  
Academic PI Faculty by Year -- 2002-2014 (N=58) 
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Table 1: Summary of CPF Completed Grants by Academic Institution, Institution Type, Grants  
Completed, AACP/NABP District, and the Number of Investigator Impact Responses Received (N=36) 
 
 
 
Name of Institution 
 
Institution 
Type 
 
Number of 
CPF Grants 
Completed 
 
AACP/ NABP 
District* 
Number of 
Faculty 
Reflection 
Responses 
Albany College of Pharmacy                                                             Private 1 2 1 
Campbell University, College of Pharmacy & Health Science Private 1 3 - 
Creighton University, School of Pharmacy Private 1 5 - 
Drake University, College of Pharmacy & Health Sciences           Private 3 5 3 
Howard University, School of Pharmacy                                          Private 1 2 1 
Massachusetts College of Pharmacy & Health Sciences Private 2 1 - 
Medical University of South Carolina                                                Public 1 3 1 
Mercer University, College of Pharmacy & Health Sciences        Private 1 3 1 
Midwestern University, College of Pharmacy-Glendale Private 1 8 - 
Northeastern University, School of Pharmacy                                  Private 1 1 1 
Nova Southeastern University, College of Pharmacy Private 1 3 - 
Ohio Northern University, College of Pharmacy                Private 1 4 1 
Oregon State University, College of Pharmacy Public 1 7 - 
South Dakota State University, College of Pharmacy                   Public 1 5 1 
Temple University, School of Pharmacy                                            Public 3 2 1 
The Ohio State University, College of Pharmacy                            Public 2 4 1 
University at Buffalo, School of Pharmacy                                       Public 1 2 1 
University of California San Francisco, School of Pharmacy         Public 1 8 1 
University of Cincinnati, College of Pharmacy Public 1 4 - 
University of Connecticut, School of Pharmacy                             Public 1 1 1 
University of Iowa, College of Pharmacy                                            Public 4 5 2 
University of Maryland, School of Pharmacy Public 1 2 - 
University of Michigan, College of Pharmacy                                   Public 3 4 1 
University of Minnesota, College of Pharmacy                               Public 2 5 2 
University of North Carolina, School of Pharmacy Public 1 3 - 
University of Pittsburgh, School of Pharmacy                                  Public 3 2 2 
University of Rhode Island, College of Pharmacy                         Public 2 1 1 
University of Southern California, School of Pharmacy                Private 1 8 1 
University of Texas at Austin, College of Pharmacy Public 3 6  
University of Wisconsin, School of Pharmacy                                   Public 4 4 2 
Virginia Commonwealth University, School of Pharmacy              Public 1 2 1 
Washington State University, College of Pharmacy                      Public 1 7 1 
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Wayne State University, College of Pharmacy                                  Public 2 4 1 
West Virginia University, School of Pharmacy                                 Public 1 2 1 
Western University of Health Sciences, College of Pharmacy       Private 2 8 2 
Xavier University of Louisiana, College of Pharmacy Private 1 6 - 
TOTAL (N=36) 22 Public  
14 Private 
58 Grants 
40 Public 
18 Private 
Eight 
Districts 
32 Responses 
*American Association of Colleges of Pharmacy (AACP) and National Association of Boards of Pharmacy (NABP) 
 
 
A. Representativeness of Academic Institutions 
To determine the degree of academic representation of CPF 
funding, the 36 academic institutions affiliated with the 58 
faculty grant awards were first plotted on a national map.  CPF 
faculty funding was then analyzed by comparing the number 
and percentage of awards in the following categories:  
 
- public and private schools and colleges of pharmacy 
- AACP/NABP Districts      
 
Public vs Private 
The distribution of CPF awards across public and private 
institutions shows that in the Initial Years (2002-2008) 54% of 
funding recipients were from public academic institutions.  In 
the Recent Years (2009-2014), this proportion was 80%.   
Table 2 presents a composite summary of all CPF grants 
awarded to faculty investigators.  
   
 
 
 
 
Table 2: Institution Type (Public and Private), for Projects Awarded to Faculty by the  
Community Pharmacy Foundation (Initial Years, 2002-2008 and Recent Years, 2009-2014) 
 
 
Institution Type 
 
Initial Years 
(2002-2008) 
n = 28 
Recent Years 
(2009-2014) 
n = 30 
Overall 
(2002-2014) 
N = 58 
 
Public 
Private 
 
 
54% 
46% 
 
80% 
20% 
 
67% 
33% 
 
 
Geographic Location 
There were 58 faculty at 36 academic institutions receiving  
CPF funding.  The geographic distribution, corresponding 
AACP/NABP Districts, and number of grants at each of the 36 
academic institutions are displayed on a map in Figure 2. Of the 
58 grants, 24% were awarded to an academic institution in 
AACP/NABP Region 4 (IL, IN, MI, OH, WI), 21% were awarded in 
Region 2 (DE, DC, MD, NJ, NY, PA, VA, WV), 16% in Region 5 (IA,  
MN, NE, ND, SD), 10% in Region 3 (AL, FL, GA, KY, MS, NC, PR, 
SC, TN, VI), 9% in Region 1 (CT, ME, MA, NH, RI, VT), 9% in 
Region 8 (AZ, CA, CO, GM, HI, NV, NM, UT), 7% in Region 6 (AR, 
KS, LA, MS, OK, TX), and 5% in Region 7 (AK, ID, MT, OR, WA, 
WY). 
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Figure 2: Geographic Distribution of CPF Grantee Academic  
Institutions by AACP/NABP District (N=36 institutions) 
 
 
Key 
Color: District 
 District 1  District 2  District 3  District 4  
District 5  District 6  District 7  District 8 
Shape: Grants Completed 
One Grant                       Two Grants                     Three Grants                  Four Grants 
B. Comparison of Scope between ‘Initial Years’ and ‘Recent 
Years’  
Funding Level 
The 58 CPF grants completed by academic PIs were  
evaluated to describe the distribution of institution type  
(public vs. private) by Initial Years (2002-2008) and Recent Years  
(2009-2014).  Table 3 displays the categorical funding levels of 
CPF projects awarded to faculty.  The distribution of dollar 
amounts for faculty-funded projects did not appear to differ 
substantially between the Initial Years and the Recent Years.  
Most projects were funded at the $25,001-$50,000 range.   
 
 
 
 
Table 3: Dollar Amount for Projects Awarded to Faculty by the  
Community Pharmacy Foundation (Initial Years, 2002-2008 and Recent Years, 2009-2014) 
 
 
Dollar Amounts 
Initial Years 
(2002-2008) 
n = 28 
Recent Years 
(2009-2014) 
n = 30 
Overall 
(2002-2014) 
N = 58 
 
< $1,000 
$1,001 - $25,000 
$25,001 - $50,000 
$50,001 - $100,000 
> $100,000 
 
 
0% 
32% 
46% 
21% 
0% 
 
3% 
30% 
53% 
13% 
3% 
 
2% 
31% 
50% 
17% 
2% 
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Three-part Aim 
The 58 CPF grants completed by academic institutions were 
evaluated to describe their contributions toward the “Three-
Part Aim” for healthcare which are, (1) improving care for 
individual patients, (2) improving population health, and (3) 
controlling health care costs through quality improvement.  The 
majority of projects that were completed in both the Initial 
Years and Recent Years made contributions to Improving Care 
for Individual Patients (Initial: 58%; Recent 56%) and Improving 
Population Health (Initial: 58%; Recent 61%). The most 
noticeable difference in the proportion of projects completed 
in the Initial Years compared with the Recent Years were 
contributions to controlling health care costs through quality 
improvement (0% and 18%, respectively).  
 
Coordinated Use of Medications 
The 58 CPF grants completed by academic institutions were 
evaluated to describe their contributions toward the 
“Coordinated Use of Medications,” which is part of the CPF’s 
Strategic Directions Plan (adopted in 2015), and calls for: (1) 
payment reform, (2) delivery reform, and (3) real-time data 
integration.  The majority of completed projects were in the 
area of Delivery Reform (72% overall). Relatively few projects 
have been in the Payment Reform (7% overall) and Real Time 
Data Integration (10% overall) strategic priority areas.   
 
Across all years, 60% of faculty projects contributed to one 
strategic priority category, 12% contributed to two categories, 
and 2% contributed to all three categories.  A similar 
distribution pattern was also present in both the Initial Years 
(2002-2008) and Recent Years (2009-2014).   
 
C. Comparison of Impact between ‘Initial Years’ and ‘Recent 
Years’  
AHRQ Impact Factor 
The academic subgroup analysis of the 58 CPF grants awarded 
to pharmacy faculty from 2002 through 2014 was also 
categorized using the AHRQ Impact Factor for describing the 
outcomes of outcomes research.  Table 4 summarizes the 
distribution of pharmacy faculty grants by AHRQ Level of 
Impact. 
 
 
 
 
 
Table 4: AHRQ Level of Impact for Completed CPF Projects  
Completed by Academic Faculty (Initial Years, 2002-2008 and Recent Years, 2009-2014) 
 
 
AHRQ Level 
Initial Years 
(2002-2008) 
n = 19 
Recent Years 
(2009-2014) 
n = 39 
Overall 
(2002-2014) 
N = 58 
Level 1: Studies that add to the knowledge base only and do not represent a 
direct change in policy or practice 
 
53% 
 
36% 
 
41% 
Level 2: Studies that may lead to a policy or program change as a direct result 
of the research. 
 
32% 
 
36% 
 
35% 
Level 3: Studies that may cause a potential change in what clinicians or 
patients do, or results in a change in a care pattern. 
 
16% 
 
26% 
 
22% 
Level 4: Studies that may change actual health outcomes (clinical, economic, 
quality of life, and/or patient satisfaction), or profoundly change practice.  
 
0% 
 
3% 
 
2% 
 
 
There is a trend towards more recently completed grants 
reaching higher AHRQ impact levels as compared to the initial 
years. The majority (53%) of the projects completed by 
academic faculty during the Initial Years were Impact Level 1.  
These studies added to the knowledge base only and did not 
represent a direct change in policy or practice.  Such studies 
were descriptive in nature and provided contributions to what 
is known about a phenomenon.  In contrast, only 36% of 
projects completed in Recent Years (2009-2014) were at Impact 
Level 1.  The majority of projects during the Recent Years were 
more likely to have an impact at Level 2 (36% of completed 
projects), Level 3 (26%), or Level 4 (3%).  The Recent Years 
projects were more focused changing policies and programs, 
clinical care and practice patterns, and health outcomes.          
The only Level 4 impact study came from a grant of more than 
$50,000.  And, for Level 1, Level 2, and Level 3 impact studies, 
the proportions of grants over $50,000 were 21%, 10%, and 
15%, respectively.  
 
CPF Investigator Reflections 
There were 32 academic investigators (or 55% of faculty 
grantees) who responded to requests for investigator influence 
statements.  Investigator influence responses were coded into 
the six categories of: (1) practice development, (2) promotion 
& advancement, (3) new & expanded collaborations, (4) 
funding opportunities, (5) awards, and (6) reimbursement 
reform.  Of the 32 investigators who provided feedback, 47% 
provided feedback in one of the categories and the remaining 
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53% of the responders provided feedback that was coded            
in two or more categories. Thus, the majority of faculty 
investigators were influenced in multiple ways by CPF funding.  
The most commonly reported categories of influence were 
practice development (59%) and promotion & advancement 
(59%), followed by new & expanded collaborations (38%), 
funding opportunities (22%), awards (22%), and 
reimbursement reform (9%). 
 
Faculty influence statements were extensive, ranging from 
three sentences to five pages of reflections.  There were a 
number of common themes that emerged in the 32 faculty 
impact statements relating specifically to grantsmanship 
experience and to conducting implementation science 
research.7 Faculty reflections related to grantsmanship 
experience were contained primarily in the categories of 
promotion & advancement, new & expanded collaborations, 
funding opportunities, and awards.  And faculty reflections 
related to implementation science research aligned with the 
practice development and reimbursement reform categories. 
 
The most common grantsmanship theme expressed by faculty 
respondents was the importance of CPF funding in launching 
their research careers by acquiring skills, experience, and 
confidence in securing funding.  Respondents also revealed that 
CPF funding resulted in new collaboration opportunities and 
was instrumental in their promotion and advancement. 
 
The most common reflections related to the implementation 
science theme focused on implementing and evaluating novel 
practice models, influencing policy decisions, measuring return 
on investment, and justifying reimbursement through 
employer and payer initiatives.  Faculty investigators also 
reported subsequent funding opportunities from CPF funded 
projects, including the U.S. Department of Health and Human 
Services, the Kellogg Foundation, the National Institutes of 
Health (NIH) career development awards, the Pharmacy Quality 
Alliance, Wisconsin Medicaid, the Catholic Diocese of Memphis, 
grants that launched an entrepreneurial institute and two 
Centers for Medicare & Medicaid Services Health Care 
Innovations Awards. 
 
Discussion 
A. Representativeness of Academic Institutions 
Public vs Private 
In the Initial Years (2002-2008), 54% of funding recipients were 
from public academic institutions, which grew to 80% In the 
Recent Years (2009-2014).  This disproportionate 
representation between public and private institutions in 
recent years may suggest that more resources are needed to 
support successful applications for faculty from private 
institutions.  
 
 
Geographic Location 
There was a broad geographic representation of faculty 
awardees at institutions across the eight AACP/NABP districts, 
with the exception of the interior West states.  This finding of 
broad geographic representation supports the CPF Board of 
Directors interest in the distribution, or diversity, of funding 
across the country and among academic institutions.  This 
representative distribution pattern is also important to 
prospective grantees with evidence of funding distributed 
across the country.   
 
B. Comparison of Scope between ‘Initial Years’ and ‘Recent 
Years’  
Funding Level 
The number and amount of grants awarded were remarkably 
similar between Initial Years and the Recent Years.  This 
consistency across time appears to reflect the CPF Board’s aim 
to fund based on estimated annual income, in order to maintain 
CPF in perpetuity. 
 
Three-Part Aim 
Over half of projects across both of the evaluated time-periods 
contributed to Improving Care for Individual Patients and 
Improving Population Health. However, there was a significant 
growth in contributions to Controlling Health Care Costs 
through quality improvement from the Initial Years (0%) to the 
Recent Years (18%).  This growth likely aligns with greater 
recognition, integration, and value measurements of the 
pharmacist role within this area by the healthcare stakeholders. 
 
Coordinated Use of Medications 
A supermajority of completed projects contributed to Delivery 
Reform (72% overall), with substantially fewer doing so for 
Payment Reform (7% overall) and Real Time Data Integration 
(10% overall).  This suggests a continued value by CPF for 
contributions to Delivery Reform, with a future emphasis on 
incorporating ‘forward looking,’ value-based benchmarks for 
payment reform and real-time data integration to address 
existing barriers and gaps in community pharmacy practice. 
 
C. Comparison of Impact between ‘Initial Years’ and 
‘Recent Years’  
AHRQ Impact Factor Framework 
The majority of faculty projects during the Initial Years were in  
Level 1 (53%), but this number dropped to roughly a third (36%) 
in the Recent Years. This trend suggests that recent CPF faculty 
projects were increasingly focused on changing policies and 
programs, clinical care and practice patterns, and health 
outcomes, rather than adding to the knowledge base about 
medical conditions and medications. 
 
CPF Investigator Reflections 
It is clear that CPF funding is having an important impact on the 
careers of colleagues in academia and funds are being used by 
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grantees to meet the mission of academic institutions.  Each 
college of pharmacy receives a funding report and ranking from 
the American Association of Colleges of Pharmacy (AACP), 
based on funding that faculty receive.  The annual AACP 
Pharmacy Faculty Research Grant Data (PFRGD) Report includes 
all types of research grants (NIH, Other Federal, Non-Federal, 
and Collaborative research grants), as long as specific 
conditions are met pertaining to peer-reviewed research.   
Based on a grantee email response, it was discovered by 
reviewing their university AACP PFRGD Report, that CPF funded 
projects were not being included due to a misconception that 
CPF studies were not peer-reviewed. Since this time, AACP and 
CPF have been collaborating to ensure that CPF funded 
research is included in the PFRGD Report of schools and 
colleges of pharmacy.  This is significant because the value of 
CPF funding, which had not been included in past AACP-PFRGD 
annual funding reports to schools and colleges of pharmacy, 
may be understated and therefore negatively impact both the 
academic institutions and the career path of individual faculty 
members.   Academic institutions may want to review their 
policies and procedures for including faculty CPF grants in their 
official accounting to AACP to determine if they are 
inadvertently undervaluing, or discrediting, the scholarly 
contributions of faculty who receive CPF funding.  
 
Implications for the Academy relates directly to strategic 
planning initiatives in collaboration with the AACP.  Recognition 
of CPF funding by AACP in the Annual PFRGD Report will 
appropriately encourage and incentivize submitting grant 
proposals.  And the results of this program evaluation analysis 
reveal that CPF funding is having an important influence on the 
careers of faculty in terms of promotion, advancement, awards, 
prestige and future funding opportunities. 
 
Limitations of this program analysis include the use of 
observational methods, which may have resulted in biased 
applications of scope and impact ratings.   Additionally, analysis 
of investigator reflections relied on respondents to the 
invitation letter, who as a group may have been fundamentally 
different in their responses than non-respondents.   
 
An important aspect of this program evaluation is the impact 
on the funding organization itself.  Critical self-reflection in 
relationship to strategic focus and direction is essential for most 
organizations.  The Community Pharmacy Foundation utilized 
the 10-year grant completion (2004-2014) milepost as an 
opportunity to conduct this program evaluation.  Based on 
findings of this program evaluation analysis, the CPF Board of 
Directors is exploring a number of quality improvement 
initiatives designed to enhance collaborations with the 
academic community nationwide. 
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